Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
about
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.Highly sensitive isotope-dilution liquid-chromatography-electrospray ionization-tandem-mass spectrometry approach to study the drug-mediated modulation of dopamine and serotonin levels in Caenorhabditis elegans.
P2860
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
@en
type
label
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
@en
prefLabel
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
@en
P2860
P1476
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
@en
P2093
Cristian Follmer
P2860
P304
P356
10.1586/14737175.2014.920235
P577
2014-06-01T00:00:00Z